Dosage form cost comparison and prescribing alternatives
Guidance for prescribers to consider clinically appropriate, lower-cost dosage form alternatives for commonly prescribed medications to reduce costs for EmblemHealth members.
No material clinical or coverage changes in this revision.
Provider Actions & Prescribing Guidance
Prior Authorization
No prior authorization requirements are specified for the medications discussed in this policy. This is informational — no PA submission is required at this time.
Suggested Prescribing Approach
Consider starting new patients on the suggested, clinically appropriate alternatives to minimize costs. For patients already stable on therapy, discuss switching to alternatives when clinically appropriate and with patient consent.
- Start new patients on suggested alternatives when possible
- Review current patients and consider switching when clinically appropriate
Denial Triggers / Guidance
There are no specific denial triggers outlined in this document. This guidance is informational and intended to help clinicians consider cost-effective alternatives; it is not a basis for claim denial.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.